AR116040A2 - 4- (6-CHLORO-3-METHYL-4,10-DIHYDRO-3H-2,3,4,9-TETRAAZABENZO [F] AZULEN-9-CARBONYL) -2-FLUORO-BENZYLAMIDE SALT TOSILATE CYCLOPROPANCARBOXYL ACID - Google Patents

4- (6-CHLORO-3-METHYL-4,10-DIHYDRO-3H-2,3,4,9-TETRAAZABENZO [F] AZULEN-9-CARBONYL) -2-FLUORO-BENZYLAMIDE SALT TOSILATE CYCLOPROPANCARBOXYL ACID

Info

Publication number
AR116040A2
AR116040A2 ARP190102468A ARP190102468A AR116040A2 AR 116040 A2 AR116040 A2 AR 116040A2 AR P190102468 A ARP190102468 A AR P190102468A AR P190102468 A ARP190102468 A AR P190102468A AR 116040 A2 AR116040 A2 AR 116040A2
Authority
AR
Argentina
Prior art keywords
tetraazabenzo
benzylamide
dihydro
fluoro
carbonyl
Prior art date
Application number
ARP190102468A
Other languages
Spanish (es)
Inventor
David R Churchley
Timothy John Kenhardt Gibbs
Valerie Elizabeth Peal
Rachel Louisa Charlotte Handy
Andrzej Roman Batt
Michael Bryan Roe
Original Assignee
Vantia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vantia Ltd filed Critical Vantia Ltd
Publication of AR116040A2 publication Critical patent/AR116040A2/en

Links

Abstract

La presente provee para-toluensulfonato de 4-(6-cloro-3-metil-4,10-dihidro-3H-2,3,4,9-tetraazabenzo[f]azulen-9-carbonil)-2-fluoro-bencilamida de ácido ciclopropancarboxílico, composiciones farmacéuticas que lo contienen, y su uso en terapia.This document provides 4- (6-chloro-3-methyl-4,10-dihydro-3H-2,3,4,9-tetraazabenzo [f] azulene-9-carbonyl) -2-fluoro-benzylamide para-toluenesulfonate of cyclopropanecarboxylic acid, pharmaceutical compositions containing it, and its use in therapy.

ARP190102468A 2010-03-19 2019-08-30 4- (6-CHLORO-3-METHYL-4,10-DIHYDRO-3H-2,3,4,9-TETRAAZABENZO [F] AZULEN-9-CARBONYL) -2-FLUORO-BENZYLAMIDE SALT TOSILATE CYCLOPROPANCARBOXYL ACID AR116040A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31546810P 2010-03-19 2010-03-19

Publications (1)

Publication Number Publication Date
AR116040A2 true AR116040A2 (en) 2021-03-25

Family

ID=75905148

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190102468A AR116040A2 (en) 2010-03-19 2019-08-30 4- (6-CHLORO-3-METHYL-4,10-DIHYDRO-3H-2,3,4,9-TETRAAZABENZO [F] AZULEN-9-CARBONYL) -2-FLUORO-BENZYLAMIDE SALT TOSILATE CYCLOPROPANCARBOXYL ACID

Country Status (1)

Country Link
AR (1) AR116040A2 (en)

Similar Documents

Publication Publication Date Title
CY1118680T1 (en) PHARMACEUTICAL COMPOSITION
CY1120438T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MY-INOSITOL AND D-KIRO-INOSITOL
CL2012003026A1 (en) Pharmaceutical composition comprising pioglitazone and linagliptin; preparation procedure; Use in the treatment of type 2 diabetes or obesity.
BR112013028908A2 (en) c-kit antibodies and uses thereof
BR112015002933A2 (en) implantable device for use in the human and / or animal body to replace an organ valve.
CL2013000322A1 (en) Compounds derived from substituted piperidine; Preparation process; Pharmaceutical composition and its use to produce an antiproliferative and / or proapoptotic effect.
UY33396A (en) 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE
PL3517539T3 (en) Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
CL2013001947A1 (en) Pharmaceutical composition comprising pioglitazone; use of pioglitazone to treat Alzheimer's; composition comprising pioglitazone.
CL2009001484A1 (en) Glycinate salt of metformin; pharmaceutical composition comprising the salt; and its use to treat hyperglycemia.
CL2014002348A1 (en) Phenicol derived compounds; pharmaceutical composition that includes them; and its use to control or treat bacterial infections in cattle.
EA201391119A1 (en) DELIVERY SYSTEMS OF NANOPARTICLES, THEIR RECEIVING AND APPLICATION
BR112013029256A8 (en) pharmaceutical combination for use in treating patients with type 2 diabetes
CL2008001123A1 (en) Compounds derived from lipoic acid; pharmaceutical formulation comprising it; and use in the treatment of cancer.
TR201909447T4 (en) Aramkol salts.
BR112014005025A2 (en) pharmaceutical composition for use in the treatment of a neurodegenerative disease
TR201910866T4 (en) Combined preparations for cancer treatment.
UY32520A (en) COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE GLUCOCORTICOESTEROID RECEPTOR
BR112013000779A2 (en) combination pharmaceutical compositions, patient treatment methods and use of activated potentiated form of angiotensin ii receptor 1 antibody and activated potentiated form of endothelial synthase antibody
BR112014011481A2 (en) collagen hydrolyzate and its use
BR112014000795A2 (en) Cosmetic and / or dermatological use of oligosaccharide compounds in the prevention and treatment of stretch marks.
CL2012003265A1 (en) Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
BR112015006272A2 (en) '' cosmetic use, compounding, cosmetic composition and method of cosmetic treatment ''
BR112014016804A8 (en) compositions, methods of use and methods of treatment
CL2008001280A1 (en) Pharmaceutical composition comprising an n-halogenated amino acid salt; preparation procedure; and its use as an antimicrobial.

Legal Events

Date Code Title Description
FB Suspension of granting procedure